OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Cleveland Clinic Lou Ruvo Center for Brain Health

4 Projects | 1 Researchers | $1,380,500 Invested

2019

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

2019 Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2014

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2 Trial) - add on funding

  • Funding Amount: $228,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2 Trial)

  • Funding Amount: $1,000,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2011

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Clinical Trials in Frontotemporal Degeneration and Related Disorders

  • Funding Amount: $2,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed